IVF
INVO Fertility, Inc. (NASDAQ)
Healthcare — Medical Devices
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.
Price History
Fundamentals
| Market Cap | $3.27M |
| P/E Ratio (TTM) | 0.01 |
| Forward P/E | -0.23 |
| EPS (TTM) | $248.92 |
| Dividend Yield | - |
| Profit Margin | -158.73% |
| Revenue Growth | 23.10% |
| ROE | -102.22% |
| Debt/Equity | 26.53 |
| Recommendation | None |
| Analyst Target | $20.00 |
| Analysts | 1 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 58.8 |
| Beta | - |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $169.60 |
| 52-Week Low | $1.20 |
| 50-Day Avg | $1.69 |
| 200-Day Avg | $9.75 |
| Avg Volume | $2.44M |
| Volume | 49.9K |
Performance Analysis
BULLISHIVF shows predominantly bullish signals based on its fundamentals and technicals.
Recent News
Last updated: Jul 02, 2026 13:16 UTC
Back to Screener Export Report